TomoTherapy Incorporated (TOMO) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts TOMO Hot Sheet
Join SI Premium – FREE
TomoTherapy Incorporated (NASDAQ: TOMO) reported Q1 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $46.95 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
- Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
